Wang Jun, Ye Chuncui, Wu Kejian, Fei Sujuan
Department of Gastroenterology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China. .
Department of Gastroenterology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China.
J Gastrointestin Liver Dis. 2022 Mar 19;31(1):67-73. doi: 10.15403/jgld-4027.
The effect of linked color imaging (LCI) compared with white light imaging (WLI) is conflicting. The aim of this meta-analysis is to compare the efficacy of LCI versus WLI for the adenoma detection.
PubMed, Embase, Google Scholar and Cochrane Library were searched up to the end of Aug 18, 2021. All randomized controlled trials (RCTs) comparing LCI with WLI were included. Dichotomous data were pooled to obtain the relative risk (RR) with a 95% confidence interval (CI), whereas continuous data were pooled using a mean difference (MD) with 95%CI.
A total of 10 RCTs involving 5,510 patients were included. The use of LCI was associated with a statistically significant improvement in adenoma detection rate (ADR), polyp detection rate (PDR), mean adenomas per patient (MAP) and mean polyp per patient (MPP) when compared to WLI (ADR: RR=1.15, 95%CI: 1.07-1.23, p=0.0001, PDR: RR=1.15, 95%CI: 1.08-1.22, p<0.0001; MAP: MD=0.18, 95%CI: 0.09- 0.28, p=0.0002; MPP: MD=0.13, 95%CI: 0.01, 0.25, p=0.03). When stratified by size, LCI group had a higher detection rate of small adenomas (<10 mm) than the WLI group. Besides, LCI showed a significant decrease in adenoma miss rate (AMR) when compared to WLI. There were no statistically significant differences between the two groups in advanced ADR (AADR), sessile serrated lesion detection rate (SDR), cecal intubation rate, insertion time, and withdrawal time.
The pooled evidence suggests that LCI can significantly improve the detection of ADR, especially for small adenomas (<10 mm). Moreover, the AMR were significantly lower using LCI compared with WLI.
与白光成像(WLI)相比,联动成像(LCI)的效果存在争议。本荟萃分析的目的是比较LCI与WLI在腺瘤检测方面的疗效。
检索截至2021年8月18日的PubMed、Embase、谷歌学术和Cochrane图书馆。纳入所有比较LCI与WLI的随机对照试验(RCT)。汇总二分数据以获得相对风险(RR)及95%置信区间(CI),而连续数据则采用均值差(MD)及95%CI进行汇总。
共纳入10项涉及5510例患者的RCT。与WLI相比,使用LCI在腺瘤检出率(ADR)、息肉检出率(PDR)、每名患者平均腺瘤数(MAP)和每名患者平均息肉数(MPP)方面有统计学显著改善(ADR:RR = 1.15,95%CI:1.07 - 1.23,p = 0.0001;PDR:RR = 1.15,95%CI:1.08 - 1.22,p < 0.0001;MAP:MD = 0.18,95%CI:0.09 - 0.28,p = 0.0002;MPP:MD = 0.13,95%CI:0.01,0.25,p = 0.03)。按大小分层时,LCI组小腺瘤(<10 mm)的检出率高于WLI组。此外,与WLI相比,LCI的腺瘤漏诊率(AMR)显著降低。两组在进展期ADR(AADR)、无蒂锯齿状病变检出率(SDR)、盲肠插管率、插入时间和退出时间方面无统计学显著差异。
汇总证据表明,LCI可显著提高ADR的检测率,尤其是对于小腺瘤(<10 mm)。此外,与WLI相比,LCI的AMR显著更低。